The main impetus for these musings is to communicate information from the Long Term Care Medical Directors' Meetings, an annual gathering of long-term care medical directors and other disciplines to discuss issues in residential geriatric care.
A recurrent theme has been the uniqueness of prescribing for the oldest of the old. This is a term that identifies those over 85 who are becoming a larger proportion of the long-term care population. There is a near absence of research in the management of chronic diseases in this population. We extrapolate the findings from the younger age groups to direct our management in the oldest of the old. However, this age group has significant changes in drug metabolism and has a very high risk for adverse reactions aggravated by drug interactions.
December 2013: Quality Documentation >
July 2013: End of Life Planning >
June 2013: Atypical Antipsychotic Medication >
May 2013: Proton Pump Inhibitors >
March 2013: Anti-hypertensive Therapies >
February 2013: Statins >
January 2013: Diabetes >